Dozens of NIH study sections — meetings in which panels of expert scientists consider which research projects the agency should support — have been canceled in recent weeks, after the Trump ...

The UK Office for Nuclear Regulation (ONR) announced that it has returned Sellafield Ltd to routine regulatory attention for physical security. “ONR has determined that physical security measures no ...

In 1972, testicular cancer was a leading killer of young men — almost uniformly fatal. Today, it has a 90 percent survival rate. The drug responsible for this miraculous reversal, Cisplatin ...

The National Institutes of Health (NIH) announced earlier this month it would be cutting billions in costs associated with federally funded research grants that go to various institutions ...

In addition, several medical associations filed a third lawsuit in the same federal court challenging the legality of the NIH Rate Change Notice. The plaintiffs in all three cases offered similar ...

Existing indirect costs range from 20%-60% of grants; NIH wants to slash them to 15%. More from Anil today; keep refreshing that STAT homepage. While health indications in the U.S. lag far behind ...

The term refers to money NIH gives institutions where NIH-funded research is taking place to support overhead expenses such as electricity, maintenance staff, or lab space rent. Massachusetts ...

It came from the Department of Health and Human Services, which oversees the NIH, and arrived with clear instructions: Post this announcement on your website immediately. The memo announced a new ...

The ONR said Sellafield could return to a "routine attention level" A watchdog has dropped the requirement for extra security checks at the UK's largest nuclear site. Sellafield, near Seascale in ...

Sellafield, near Seascale in Cumbria, was under "enhanced" scrutiny by the Office for Nuclear Regulation (ONR) for its physical security - measures against "theft and sabotage of nuclear materials".

The CEO of Gaithersburg’s miRecule Inc. was a former oncology researcher with the National Cancer Institute who spun his business out of the NIH in 2016. The company has since secured millions ...

He said his research is almost entirely reliant on NIH grants. The search for a cure for these rare disorders is a race against time, because researchers think treatment will be most effective if ...